Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prospective Role of Epigenetics in Attention-deficit/Hyperactivity Disorderdeficit/Hyperactivity Disorder

NCT04860024 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.

NCT NCT04860024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04860024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prospective Role of Epigenetics in Attention-deficit/Hyperactivity Disorderdeficit/Hyperactivity Disorder
Lead sponsor
Chang Gung Memorial Hospital
Phase
Observational
Overall status
Completed
Start date
August 31, 2015
Completion date
July 31, 2018
Enrollment
235 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

micrornas in attention-deficit/hyperactivity disorder